Teaching physicians about different measures of risk reduction may alter their treatment preference

Sozial- und Praventivmedizin

Volumn 43, Issue 2, 1998, Pages 67-72

  Bucher, Heiner C ^a   Morabia, Alfredo ^b  

^a KANTONSSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CASE REPORT; CORONARY RISK; HUMAN; ISCHEMIC HEART DISEASE; MALE; MEDICAL EDUCATION; RISK FACTOR; RISK MANAGEMENT; WORKSHOP;

ADULT; AGED; CARDIOVASCULAR DISEASES; CURRICULUM; EDUCATION; EDUCATION, MEDICAL, CONTINUING; HUMANS; INTERNAL MEDICINE; MALE; RISK FACTORS; SWITZERLAND;

EID: 0031920826     PISSN: 03038408     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01359226     Document Type: Article

References (14)

1. Naylor CD, Chen E, Siraus B. Measured enthusiasm: does the method of reporting trial results alter perceptions of therapeutic effectiveness? Ann Intern Med 1992; 117:916-921.
2. Forrow L, Taylor WC, Arnold RM. Absolutely relative: how research results are summarized can affect treatment decisions. Am J Med 1992; 92:121-124.
3. Bobbio M, Demichells B, Glustetto C. Completeness of reporting trial results: effect on physicians' willingness to prescribe. Lancet 1994; 343:1209-1211.
4. Bucher HC, Weinbacher M, Gyr K. Influence of method of reporting study results on decision of physicians to prescribe drugs to lower cholesterol concentration. BMJ 1994; 309:761-764.
5. Sackett DL, Cook RJ. Understanding clinical trials. BMJ 1994; 309: 755-756.
6. Brett AS. Treating hypercholesterolemia. How should practicing physicians interpret the published data for patients? N Engl J Med 1989; 13:764-766.
7. Morabia A. L'épidémiologie clinique. Que sais-je? No3158. Paris: PUF, 1996.
8. Laupacis A, Sackett DL, Roberts R. An assessment of clinically useful measures of the consequences of treatment. N Engl J Med 1988; 318:1728-1733.
9. Sackett DL, Haynes RB, Guyatt GH, Tugwell P. Clinical epidemiology. 2nd ed. Boston: Little, Brown, 1991.
10. Guyatt CH, Sackett DL, Cook DJ for the Evidence-Based Medicine Working Group. User's guides to the medical literature. II. How to use an article about therapy prevention. B. What were the results and will they help me in carrying for my patients? JAMA 1994; 271:59-63.
11. Wilson PWF, Castelli WP, Kannel WB. Coronary risk prediction in adults (The Framingam Heart Study). Am J Cardiol 1987; 59: 91G-94G.
12. Malenka DJ, Baron JA. Cholesterol and coronary heart disease. The importance of patient-specific attributable risk. Arch Intern Med 1988; 148:2247-2252.
13. Hirschel B, Lazzarini A, Chopard P, et al. A controlled study of inhaled pentamidine for primary prevention of Pneumocystis carinii pneumonia. N Engl J Med 1991; 324:1079-1083.
14. SAS Institute Inc. SAS/STAT User's Guide, Version 6, Fourth Edition, Volume 1, Cary, NC: SAS Institute Inc. 1989.